ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

At A Glance: This Prescriber in 2012

Internal Medicine

Self-Reported Primary Specialty

See Other Prescribers With This Specialty in This State »

38,533Medicare Part D Prescriptions Filled, Including Refills

Rank: 6 out of 1454

$2.22M Total Retail Price of All Prescriptions

Rank: 8 out of 1454

1,247 Patients Receiving at Least One Drug in Part D
69%Patients 65 Years and Older
80% Subsidized Claims for Low-Income Patients

How Does This Prescriber Compare to Peers?

In the same specialty and state. Caveats »

Drugs That Present Special Risks
Costs of Prescribing
Higher avg Average for
this specialty
in North Carolina
Lower avg

Schedule Two
Controlled Substances

10% of this provider’s 1,247 patients filled at least one prescription for a schedule two drug, compared to an average of 5%.

Schedule Three
Controlled Substances

18% of this provider’s 1,247 patients filled at least one prescription for a schedule three drug, compared to an average of 9%.

Risky Drugs to Seniors

3% of this provider’s 28,199 prescriptions for patients 65 and older were for "potentially dangerous" drugs, compared to an average of 1%.

Brand Name Drugs

28% of this provider’s prescriptions were for brand-name drugs, compared to an average of 26%.

Prescription Price

$58 was the average price of a prescription from this provider, compared to $58 among peers.

Prescriptions per Patient

31 is the average number of prescriptions (including refills) per patient, compared to an average of 21.


Another View

This chart shows a different comparison of all providers in this specialty based on their mix of drugs and volume. Providers are grouped by similarity; those least like their peers are farthest to the right. Hover over the bars to see names of other prescribers.

← Prescribers more like their peers Prescribers less like their peers →
KEY: How to read this
chart

Fewer Prescribers
More Prescribers

This Prescriber
Hover to see more prescribers

This Prescriber's Drugs

The table below list this provider’s drugs, the number of prescriptions and how many went to seniors. Drugs are ranked by volume and compared with the rank for all providers in the same specialty and state.

Click to Filter by Category

Clear Filter


S2

A schedule two drug. More » Schedule two drugs have a high potential for abuse and severe dependence, according to the Drug Enforcement Administration.

S3

A schedule three drug. More » Schedule three drugs have potential for abuse and dependence, according to the Drug Enforcement Administration.

A

An antipsychotic drug. More » Antipsychotics are frequently given to dementia patients, though it increases their risk of death.

R

A risky drug for seniors. More » The American Geriatrics Society has said this drug is "potentially dangerous" for seniors and might be inappropriate.

10

This provider is among the top 10 prescribers of
this drug in the country.

This provider’s prescriptions for this drug were for more days than those of peers. More » Because of this, his or her prescription count may be lower.

This provider’s prescriptions for this drug were for fewer days than those of peers. More » Because of this, his or her prescription count may be higher.

This Drug's Rank
Drug Name Total Prescriptions Filled
Including Refills
Prescriptions
to 65+
Category For this Prescriber For All Prescribers in
This Specialty in North Carolina
SIMVASTATIN 1,291 1,014 1 1
FUROSEMIDE 1,226 961 2 6
AMLODIPINE BESYLATE 1,177 888 3 2
OMEPRAZOLE 1,155 831 4 3
LISINOPRIL 1,087 689 5 4
METOPROLOL TARTRATE 1,030 809 6 10
POTASSIUM CHLORIDE 951 771 7 15
LEVOTHYROXINE SODIUM 885 721 8 5
HYDROCHLOROTHIAZIDE 791 526 9 9
HYDROCODONE-ACETAMINOPHEN 661 448 S3 10 7
WARFARIN SODIUM 623 496 11 17
METFORMIN HCL 615 377 12 8
ZOLPIDEM TARTRATE 554 386 13 19
ATORVASTATIN CALCIUM 553 455 14 11
TAMSULOSIN HCL 496 383 15 34
CRESTOR 465 373 16 22
GLIMEPIRIDE 459 359 17 33
METOPROLOL SUCCINATE 443 351 18 13
KLOR-CON M20 394 289 19 54
LOSARTAN POTASSIUM 393 326 20 14
LISINOPRIL-HYDROCHLOROTHIAZIDE 382 244 21 27
DONEPEZIL HCL 379 346 22 29
DIOVAN 369 273 23 40
ATENOLOL 365 246 24 18
NAMENDA 362 327 25 48
AMLODIPINE BESYLATE-BENAZEPRIL 358 266 26 65
GABAPENTIN 329 221 27 16
HYDRALAZINE HCL 314 197 28 67
CARVEDILOL 314 224 28 24
PRAVASTATIN SODIUM 311 243 30 12
SERTRALINE HCL 283 194 31 26
JANUVIA 273 188 32 77
NEXIUM 269 149 33 23
CLOPIDOGREL 266 195 34 32
TRAMADOL HCL 248 190 35 20
CITALOPRAM HBR 231 144 36 21
LACTULOSE 226 161 37 152
ISOSORBIDE MONONITRATE ER 225 198 38 46
EXELON 220 220 39 135
DIOVAN HCT 213 153 40 75
SPIRIVA 210 178 41 52
ALLOPURINOL 209 180 42 28
CYMBALTA 196 116 43 55
DILTIAZEM 24HR CD 196 173 43 76
CLONIDINE HCL 194 120 45 49
BENAZEPRIL HCL 189 163 46 57
DIGOXIN 187 147 47 70
ESCITALOPRAM OXALATE 186 168 48 78
OXYCODONE-ACETAMINOPHEN 180 102 S2 49 60
LANTUS 178 105 50 51
MIRTAZAPINE 177 172 51 53
TRAZODONE HCL 175 96 52 50
PREDNISONE 173 132 53 36
QUETIAPINE FUMARATE 171 141 54 91
PANTOPRAZOLE SODIUM 170 128 55 31
PHENYTOIN SODIUM EXTENDED 169 85 56 138
AZITHROMYCIN 167 123 57 42
PLAVIX 166 129 58 45
MELOXICAM 164 67 59 37
LIPITOR 157 133 60 74
ACETAMINOPHEN-CODEINE 156 96 S3 61 179
ZETIA 155 93 62 69
FAMOTIDINE 153 125 63 88
ACTOS 151 117 64 90
LATANOPROST 146 129 65 209
JANTOVEN 144 112 66 100
CYCLOBENZAPRINE HCL 144 60 R 66 59
PROMETHAZINE HCL 142 92 R 68 82
ATENOLOL-CHLORTHALIDONE 141 133 69 203
MEGESTROL ACETATE 139 121 R 70 219
PROAIR HFA 138 88 71 56
LANTUS SOLOSTAR 136 100 72 79
RAMIPRIL 134 114 73 66
METOCLOPRAMIDE HCL 131 62 74 121
MECLIZINE HCL 129 104 75 132
HYDROXYZINE HCL 123 98 R 76 183
LABETALOL HCL 122 63 77 147
LOSARTAN-HYDROCHLOROTHIAZIDE 121 95 78 38
SULFAMETHOXAZOLE-TRIMETHOPRIM 119 79 79 108
POLYETHYLENE GLYCOL 3350 118 93 80 61
LYRICA 117 83 81 103
RANITIDINE HCL 116 62 82 43
NOVOLOG 113 87 83 99
NAPROXEN 113 53 83 122
COLCRYS 111 86 85 116
GLIPIZIDE XL 111 96 85 85
OXYCODONE HCL-ACETAMINOPHEN 109 53 S2 87 93
FLUTICASONE PROPIONATE 108 73 88 30
BENZTROPINE MESYLATE 107 38 R 89 174
AMITRIPTYLINE HCL 107 72 R 89 71
ADVAIR DISKUS 107 99 89 47
GLYBURIDE-METFORMIN HCL 103 66 R 92 139
GLIPIZIDE 100 65 93 62
PAROXETINE HCL 99 47 94 73
CARBIDOPA-LEVODOPA 97 97 95 130
VENTOLIN HFA 97 77 95 112
HUMALOG 95 55 97 153
TRAVATAN Z 94 55 98 218
ROPINIROLE HCL 94 72 98 96
LEVETIRACETAM 93 55 100 114
DILTIAZEM ER 93 88 100 126
CIPROFLOXACIN HCL 91 68 102 64
TRIAMTERENE-HCTZ 88 74 103 44
FENTANYL 88 54 S2 103 104
HALOPERIDOL 87 66 105 220
ONGLYZA 87 48 105 197
COUMADIN 87 87 105 119
SYNTHROID 87 86 105 25
INSULIN SYRINGE 82 61 109 97
TRIAMCINOLONE ACETONIDE 82 58 109 142
DIVALPROEX SODIUM 82 51 109 106
RISPERIDONE 81 61 112 86
NITROFURANTOIN MONO-MACRO 80 74 113 217
VERAPAMIL ER 80 67 113 89
AGGRENOX 79 66 115 161
COMBIVENT 78 73 116 115
DETROL LA 78 63 116 225
IBUPROFEN 76 40 118 107
PIOGLITAZONE HCL 76 55 R 118 235
AMIODARONE HCL 75 54 120 223
DIVALPROEX SODIUM ER 75 35 120 222
LEVOFLOXACIN 75 66 120 95
KLOR-CON M10 73 50 123 145
SYMBICORT 73 54 123 143
BACLOFEN 73 21 123 146
DILANTIN 71 70 126 244
NOVOLOG FLEXPEN 70 46 127 157
LEVEMIR FLEXPEN 69 55 128 171
FLUOXETINE HCL 69 43 128 72
TERAZOSIN HCL 68 58 130 155
OLANZAPINE 67 42 131 163
INDOMETHACIN 67 49 R 131 295
JANUMET 66 52 133 238
FELODIPINE ER 66 42 133 159
ALENDRONATE SODIUM 65 42 135 35
PRAMIPEXOLE DIHYDROCHLORIDE 64 45 136 200
OXYBUTYNIN CHLORIDE 64 38 136 169
SINGULAIR 61 34 138 83
ENABLEX 60 36 139 313
LUMIGAN 60 48 139 341
OXYCODONE HCL 60 0 S2 139 80
DICLOFENAC SODIUM 59 34 142 118
XOPENEX HFA 58 30 143 450
LEVEMIR 58 42 143 202
SEROQUEL 57 46 145 177
CELEBREX 57 44 145 81
RENVELA 57 46 145 232
NOVOLIN R 56 50 148 180
NITROSTAT 55 47 149 208
TOPIRAMATE 54 18 150 192
KETOCONAZOLE 52 44 151 260
PROPRANOLOL HCL 52 50 151 129
SPIRONOLACTONE 52 13 151 63
LANSOPRAZOLE 50 49 154 140
METOLAZONE 50 44 154 216
About This Data

ProPublica obtained prescribing data from Medicare’s prescription drug benefit, known as Part D, under the Freedom of Information Act. The data for 2012 includes more than 1.2 billion prescriptions written by nearly 1.5 million doctors, nurses and other providers. This database lists about 382,000 of those providers who wrote 50 or more prescriptions for at least one drug that year. Almost three-fourths went to patients 65 and older; the rest were for disabled patients. Methodology »

Incorrect Info?

If you are a provider and you believe your address is incorrect, check the listing you created on the National Provider Identifier registry. If you change your listing, send a note to drugs@propublica.org and we will update your information. If you have other questions about this data, send a note to drugs@propublica.org.

Caveats
  • No comparisons are shown if 10 or fewer prescribers in the state share this specialty.
  • The list of top drugs includes only those for which this provider wrote 50 or more prescriptions, but all prescriptions are counted in the summary totals at the top.
  • The calculation of “Risky Drugs to Seniors” does not include drugs for which a provider wrote 11 or fewer prescriptions because Medicare redacted the information to protect patient privacy.
  • Comparisons do not take into account the medical conditions of patients. Medications for certain conditions do not have generic alternatives, so patients would receive more expensive brand name drugs.
  • This provider's address and specialty information was last updated on May 2, 2013.
  • Comparisons are based on each provider’s current address, not necessarily where he or she worked during the time period covered in this database.